Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN103319417A details a novel synthesis for Triclabendazole Sulfoxide, offering higher purity and reduced environmental impact for veterinary drug manufacturing.
Patent CN111646889B details a green nickel-catalyzed route for GC-24 and Furegrelate, eliminating corrosive reagents and reducing steps for cost-effective API intermediate manufacturing.
Patent CN103408497A reveals high-yield L-carnosine synthesis. Enhances supply chain reliability and reduces manufacturing costs for global pharmaceutical partners.
Patent CN1849324A reveals a stable crystallization process for 3-chloromethyl-3-cephem derivatives, offering high purity and cost-effective recycling for antibiotic manufacturing.
Discover the advanced Pd-catalyzed Catellani reaction for synthesizing 2-aminocinnamyl alcohol esters. High stereoselectivity, mild conditions, and reliable supply chain solutions.
Patent CN1203080C reveals novel camphorate-based platinum compounds with low toxicity. Discover cost-effective synthesis routes for high-purity pharmaceutical intermediates.
Patent CN117660389A reveals mutant transaminase for chiral amines. Offers high conversion and purity for pharma and agrochemical manufacturing supply chains.
Patent CN110256519A reveals a one-pot synthesis for Ulipristal Acetate. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel Lewis acid catalysis method for EGFR inhibitor formula I ensures high purity and scalability. Reduced impurities offer reliable pharma intermediate supplier advantages for global procurement teams.
Patent CN107383030A reveals novel spiro-oxindole synthesis via 1,3-dipolar cycloaddition. Offers high purity pharmaceutical intermediates with scalable production capabilities.
Patent CN102887885A details a high-purity Esomeprazole Sodium synthesis via inclusion complex resolution, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel four-step synthesis of key dexamethasone intermediate offering high yield and purity for scalable API manufacturing supply chains.
Patent CN110372566B details a novel asymmetric rearrangement method yielding high-purity oxindoles with quaternary centers, offering significant cost and supply chain advantages.
Patent CN103864637B reveals a mild TfOH-catalyzed route for N-(β-nitroalkyl) amides. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable methods.
Novel sulfonylation route for Aprocitentan reduces costs and improves purity. Ideal for pharmaceutical intermediate manufacturing and commercial scale-up.
Novel synthesis of Erlotinib-13C6 using Benzene-13C6. Optimized route for metabolic studies. Cost-effective manufacturing solution for global pharma.
Patent CN105358687B reveals surface displayed designer cells for efficient chiral alcohol production offering significant supply chain and cost advantages for pharmaceutical manufacturing.
Patent CN113045416A reveals a streamlined two-step synthesis for ketone body precursors, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Novel synthesis of Imatinib using safe conditions. Reduces cost and eliminates cis-trans screening. Ideal for pharma manufacturing supply chains.
Novel patent CN104725335B details high-purity Escitalopram Hydrobromide synthesis. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing partners.